A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

Raija Silvennoinen,Pekka Anttila,Marjaana Säily,Tuija Lundán,Jouni Heiskanen,Timo Siitonen,Sakari Kakko,Mervi Putkonen,Hanna Ollikainen,Venla Terävä,Anu Kutila,Kirsi Launonen,Anu Räsänen,Anu Sikiö,Merja Suominen,Piotr Bazia,Kristiina Kananen,Tuomas Selander,Taru Kuittinen,Kari Remes,Esa Jantunen

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

2016

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

Keywords:

Immunology
Progenitor cell
Lenalidomide
Bortezomib
Thalidomide
Stem cell
Medicine
Plerixafor
Cyclophosphamide
Multiple myeloma
Phases of clinical research
Transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations